System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Michele Senni is an expert in Cardiology at Ospedale Papa Giovanni XXIII (Italy). As of October 2026, ScienceLeadR ranks Michele Senni in the top 1% of experts worldwide for Heart Failure, Coronavirus Infections and COVID-19. Michele Senni has authored 682 publications, the most recent in 2026, and is an investigator in 55 clinical trials, 11 of them ongoing. SLR score: 3,113 (community average: 125). How the SLR is computed.

LeadR Profile

Michele Senni Ospedale Papa Giovanni XXIII Italy
3 113 ScienceLeadR Reputation 3113

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Endocrinology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1997 - 2026
Source: PubMed

Ospedale Papa Giovanni XXIII

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 682

Citations

Citations: 78 969 1st author: 44 Last author: 118 Unique author: 3

Main journals

Eur J Heart Fail 88
J Am Coll Cardiol 47
Eur Heart J 43
G Ital Cardiol (Rome) 40
Circulation 33

Best Journals

N Engl J Med 24
Eur Heart J 17
Circulation 11

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prevalence and prognostic role of left atrial reverse remodeling in patients undergoing mitral transcatheter edge-to-edge repair: insights from the Multicenter Echocardiographic Registry of patients undergoing mitral Transcatheter Edge-to-Edge Repair.
PMID 42886843 — registries, mortality, hospitalization, heart failure, heart, cardiovascular diseases, prevalence, mitral valve insufficiency		J Cardiovasc Med (Hagerstown)20260
Sex-Based Differences in Chronic Heart Failure: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PMID 42876202 — heart failure, pharmaceutical preparations, heart, heart failure, diastolic, heart failure, systolic, sex, therapeutics		Eur J Heart Fail20260
Nurse led titration of guideline-directed medical therapy for heart failure: an operative flow chart.
PMID 42836327 — nurses, heart failure, heart, multiple chronic conditions, therapeutics		ESC Heart Fail20260
Heart failure with mid-range or preserved ejection fraction: temporal trends in an individual patient data meta-analysis of trials.
PMID 42799541 — heart failure, heart, cardiology		Eur Heart J Top journal20260
Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure: The FINEARTS-HF Randomized Clinical Trial.
PMID 42776557 — kidney diseases, heart failure, heart, cardiovascular diseases, kidney		JAMA Cardiol20260

Clinical Studies 55

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 36
Phase 2 13
N/A 4
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 37
Recruiting 6
Terminated 4
Not yet recruiting 3
Unknown 3
Active not recruiting 2

By type:

Interventional 52
Observational 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 2
multicentricup10 48

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

11 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
An open label extension (OLE) trial to evaluate long term safety and tolerability of pelacarsen (TQJ230)
2024-519870-38-00 — safety, cardiovascular diseases		Phase 3Not yet recruiting2026
HF POLARIS A research study to look at how well NNC0487 0111 works compared to placebo in people with heart failure and obesity
2025-523717-29-00 — mortality, safety, heart failure, heart, heart failure, diastolic, obesity, morbidity, research		Phase 3Recruiting2026
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure and a weak pumping function of the left side of the heart
2024-519525-38-00 — safety, heart failure, heart		Phase 3Not yet recruiting2025
A Phase III Study to Investigate the Risk of Incident Heart Failure and Cardiovascular Death with Baxdrostat in Combination with Dapagliflozin in Participants with Increased Risk of Developing Heart Failure
2024-514506-32-00 — heart failure, heart		Phase 3Not yet recruiting2025
202301CPC Redefine HF
2023-508581-15-00 — mortality, safety, heart failure, heart, morbidity		Phase 3Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS